Prokidney (PROK) Accumulated Expenses (2021 - 2026)

Prokidney (PROK) has 6 years of Accumulated Expenses data on file, last reported at $22.2 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 19.37% year-over-year to $22.2 million in Q1 2026; TTM through Mar 2026 was $22.2 million, a 19.37% decrease from a year earlier, with the FY2025 full-year figure at $28.7 million, down 7.73% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $22.2 million, down from $28.7 million in the prior quarter.
• Over the last five years, Accumulated Expenses for PROK reached as high as $31.1 million in Q4 2024 and fell as low as $5.3 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $17.5 million across 5 years, with a median of $17.7 million in 2023.
• Across the five-year window, Accumulated Expenses jumped 8639715.91% in 2022 and slipped 27.86% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $7.3 million in 2022, then jumped by 140.8% to $17.7 million in 2023, then surged by 76.26% to $31.1 million in 2024, then retreated by 7.73% to $28.7 million in 2025, then slipped by 22.62% to $22.2 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $22.2 million in Q1 2026, $28.7 million in Q4 2025, and $26.1 million in Q3 2025.